Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for prevention of post-ERCP pancreatitis
2009-013294-18Phase 3Terminated
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) comparing Magnesium sulfate with Placebo (2 arms). Primary endpoint: Incidence of post-ERCP pancreatitis. Started Oct 2009; status: terminated.
02
Drugs
magnesium sulfate
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on 2009-013294-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013294-18.